Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Saint Mary's Duluth Clinic Health System
mi
from
Duluth, MN
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Saint Mary's Duluth Clinic Health System
mi
from
Duluth, MN
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Mayo Clinic College of Medicine, Dept. of Anesthesiology
mi
from
Rochester, MN
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Mayo Clinic College of Medicine, Dept. of Anesthesiology
mi
from
Rochester, MN
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
University of Missouri
mi
from
Columbia, MO
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Mount Sinai School of Medicine
mi
from
Great Neck, NY
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Mount Sinai School of Medicine
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
New York Univ. Medical Center
mi
from
New York, NY
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
New York Univ. Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Duke Univ Med Ctr
mi
from
Durham, NC
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Ohio State University Medical Center
mi
from
Columbus, OH
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
University of Pittsburgh Medical Center-Presbyterian
mi
from
Pittsburgh, PA
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
University of Pittsburgh Medical Center-Presbyterian
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Research Concepts
mi
from
Bellaire, TX
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Research Concepts
mi
from
Bellaire, TX
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
Parkland Health and Hospital System
mi
from
Dallas, TX
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
Parkland Health and Hospital System
mi
from
Dallas, TX
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
University of Virginia Health Systems
mi
from
Charlottesville, VA
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
University of Virginia Health Systems
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
University of Wisconsin Medical School, Dept. of Anesthesiology
mi
from
Madison, WI
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
University of Wisconsin Medical School, Dept. of Anesthesiology
mi
from
Madison, WI
Click here to add this to my saved trials
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated:  7/23/2015
VA Medical Center
mi
from
Milwaukee, WI
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia
Status: Enrolling
Updated: 7/23/2015
VA Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Intravenous Iron Metabolism in Restless Legs Syndrome
Intravenous Iron Metabolism in Restless Legs Syndrome
Status: Enrolling
Updated:  7/23/2015
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Intravenous Iron Metabolism in Restless Legs Syndrome
Intravenous Iron Metabolism in Restless Legs Syndrome
Status: Enrolling
Updated: 7/23/2015
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Antiepileptic Drugs and Osteoporotic Prevention Trial
Antiepileptic Drugs and Osteoporotic Prevention Trial
Status: Enrolling
Updated:  7/23/2015
VA Boston Healthcare System
mi
from
Boston, MA
Antiepileptic Drugs and Osteoporotic Prevention Trial
Antiepileptic Drugs and Osteoporotic Prevention Trial
Status: Enrolling
Updated: 7/23/2015
VA Boston Healthcare System
mi
from
Boston, MA
Click here to add this to my saved trials
Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial
Field Administration of Stroke Therapy-Magnesium Trial: A Randomized, Double-Blind, Placebo Controlled Trial of Neuroprotective Magnesium Sulfate Therapy for Acute Stroke Initiated Within 2 Hours of Onset by Paramedics in the Field
Status: Enrolling
Updated:  7/24/2015
The Clinical Coordinating Center is: UCLA School of Medicine, 710 Westwood Plaza
mi
from
Los Angeles, CA
Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial
Field Administration of Stroke Therapy-Magnesium Trial: A Randomized, Double-Blind, Placebo Controlled Trial of Neuroprotective Magnesium Sulfate Therapy for Acute Stroke Initiated Within 2 Hours of Onset by Paramedics in the Field
Status: Enrolling
Updated: 7/24/2015
The Clinical Coordinating Center is: UCLA School of Medicine, 710 Westwood Plaza
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
San Diego, CA
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Pompano Beach, FL
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Pompano Beach, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Sunrise, FL
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Sunrise, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Rome, GA
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Rome, GA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
New Bedford, MA
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
New Bedford, MA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Detroit, MI
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Raleigh, NC
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Dayton, OH
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Round Rock, TX
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Round Rock, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Roanoke, VA
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Tacoma, WA
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Redding, CA
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Redding, CA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Fairfield, CT
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Fairfield, CT
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Dover, DE
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Dover, DE
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Miami, FL
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Naples, FL
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Naples, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Sarasota, FL
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Columbus, GA
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Elk Grove Village, IL
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Baltimore, MD
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Worcester, MA
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Golden Valley, MN
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
St Louis, MO
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Plainview, NY
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Plainview, NY
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Charlotte, NC
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Hickory, NC
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Hickory, NC
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Matthews, NC
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Matthews, NC
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Wilmington, NC
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials